Brief: Sprint Bioscience Collaborates With LG Chem

Sprint Bioscience AB

28/03/2019 07:53

March 28 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * SPRINT BIOSCIENCE COLLABORATE WITH LG CHEM TO DEVELOP
NOVEL
TREATMENTS FOR NASH AND METABOLIC DISORDERS
    * UNDER TERMS OF AGREEMENT, SPRINT BIOSCIENCE IS ELIGIBLE TO
RECEIVE UPFRONT AND RESEARCH FUNDING DURING FIRST 12 MONTHS
    * SPRINT BIOSCIENCE IS ELIGIBLE TO RECEIVE ROYALTIES ON
WORLDWIDE
NET SALES OF ANY RESULTING PRODUCTS UNDER COLLABORATION.
    * UNDER TERMS OF AGREEMENT CO IS ELIGIBLE TO GET POTENTIAL
ADDITIONAL RESEARCH FUNDING, PRECLINICAL, CLINICAL AND NET
SALES-BASED MILESTONE PAYMENTS TOTALING UP TO APPROXIMATELY USD
230 MILLION

Source text for Eikon:  ID:nWkr8nyM3x 
Further company coverage:  SPRINT.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))